Why a Successful Phase II Trial Does Not Automatically Mean Phase III Will Succeed
In drug development, transitioning from early exploratory studies to late-stage confirmatory investigations represents one of the most demanding hurdles for clinical sponsors. While achieving positive results in early i…
